Terns Pharmaceuticals Stock Price on December 18, 2024
| TERN Stock | USD 5.88 0.08 1.38% |
If you're considering investing in Terns Stock, it is important to understand the factors that can impact its price. As of today, the current price of Terns Pharmaceuticals stands at 5.88, as last reported on the 26th of December, with the highest price reaching 5.95 and the lowest price hitting 5.65 during the day. Terns Pharmaceuticals owns Efficiency Ratio (i.e., Sharpe Ratio) of -0.12, which indicates the firm had a -0.12% return per unit of risk over the last 3 months. Terns Pharmaceuticals exposes twenty-two different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please validate Terns Pharmaceuticals' Risk Adjusted Performance of (0.09), variance of 16.79, and Coefficient Of Variation of (821.54) to confirm the risk estimate we provide.
Terns Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
Terns |
Sharpe Ratio = -0.1217
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | TERN |
Estimated Market Risk
| 4.1 actual daily | 36 64% of assets are more volatile |
Expected Return
| -0.5 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.12 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Terns Pharmaceuticals is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Terns Pharmaceuticals by adding Terns Pharmaceuticals to a well-diversified portfolio.
Terns Pharmaceuticals Valuation on December 18, 2024
It is possible to determine the worth of Terns Pharmaceuticals on a given historical date. On December 18, 2024 Terns was worth 6.66 at the beginning of the trading date compared to the closed value of 5.76. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Terns Pharmaceuticals stock. Still, in general, we apply an absolute valuation method to find Terns Pharmaceuticals' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Terns Pharmaceuticals where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Terns Pharmaceuticals' related companies.
| Open | High | Low | Close | Volume | |
| 6.96 | 7.11 | 6.79 | 6.80 | 1,342,341 | |
12/18/2024 | 6.66 | 6.70 | 5.70 | 5.76 | 3,287,363 |
| 5.82 | 6.06 | 5.46 | 6.05 | 3,238,248 |
| Backtest Terns Pharmaceuticals | | | Terns Pharmaceuticals History | | | Terns Pharmaceuticals Valuation | Previous | Next |
Terns Pharmaceuticals Trading Date Momentum on December 18, 2024
| On December 19 2024 Terns Pharmaceuticals was traded for 6.05 at the closing time. The top price for the day was 6.06 and the lowest listed price was 5.46 . The trading volume for the day was 3.2 M. The trading history from December 19, 2024 was a factor to the next trading day price boost. The trading price change against the next closing price was 5.03% . The trading price change against the current closing price is 0.35% . |
Terns Pharmaceuticals Fundamentals Correlations and Trends
By evaluating Terns Pharmaceuticals' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Terns Pharmaceuticals' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Terns financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Terns Pharmaceuticals Stock history
Terns Pharmaceuticals investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Terns is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Terns Pharmaceuticals will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Terns Pharmaceuticals stock prices may prove useful in developing a viable investing in Terns Pharmaceuticals
Terns Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops small-molecule single-agent and combination therapy candidates for the treatment of non-alcoholic steatohepatitis and obesity. The company was incorporated in 2016 and is headquartered in Foster City, California. Terns Pharmaceuticals operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 41 people.
Terns Pharmaceuticals Stock Technical Analysis
Terns Pharmaceuticals technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Terns Pharmaceuticals Period Price Range
Low | December 26, 2024
| High |
0.00 | 0.00 |
Terns Pharmaceuticals cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Terns Pharmaceuticals December 26, 2024 Market Strength
Market strength indicators help investors to evaluate how Terns Pharmaceuticals stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Terns Pharmaceuticals shares will generate the highest return on investment. By undertsting and applying Terns Pharmaceuticals stock market strength indicators, traders can identify Terns Pharmaceuticals entry and exit signals to maximize returns
Terns Pharmaceuticals Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Terns Pharmaceuticals' price direction in advance. Along with the technical and fundamental analysis of Terns Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Terns to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | (0.09) | |||
| Jensen Alpha | (0.59) | |||
| Total Risk Alpha | (0.73) | |||
| Treynor Ratio | (0.26) |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Terns Pharmaceuticals. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. To learn how to invest in Terns Stock, please use our How to Invest in Terns Pharmaceuticals guide.You can also try the Positions Ratings module to determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Terns Pharmaceuticals. If investors know Terns will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Terns Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Terns Pharmaceuticals is measured differently than its book value, which is the value of Terns that is recorded on the company's balance sheet. Investors also form their own opinion of Terns Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Terns Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Terns Pharmaceuticals' market value can be influenced by many factors that don't directly affect Terns Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Terns Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Terns Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Terns Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.